Back to newsAptarGroup Inc <ATR.N>: BofA Global Research Raises Price Objective to $173 From $148AATR•2026-07-14Related NewsBBiogen plans Phase 3 development of Alzheimer’s tau therapy diranersen after Phase 2 data